Condition
Psychosis Associated With Alzheimer's Disease clinical trials and research
Research outlook What's coming for Alzheimer's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Psychosis Associated With Alzheimer's Disease clinical trials that are recruiting, at sites in 32 countries (most in South Korea (4), United States (4), Bulgaria (3)). By phase: Phase 3 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 32Countries
Newest Psychosis Associated With Alzheimer's Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ML-007C-MA for hallucinations and delusions in Alzheimer's disease | Phase 2 | Phoenix, Arizona and 61 other locations | Recruiting | Mar 20, 2025 |
| KarXT for psychosis in people with Alzheimer's disease | Phase 3 | Chandler, Arizona and 156 other locations | Recruiting | Nov 13, 2023 |
| Long-term safety assessment of KarXT for Alzheimer's-related psychosis | Phase 3 | Homewood, Alabama and 431 other locations | Recruiting | Aug 8, 2023 |
| Evaluating KarXT for treating psychosis in Alzheimer's patients | Phase 3 | Homewood, Alabama and 128 other locations | Recruiting | Aug 23, 2022 |
All recruiting trials (4)
-
ML-007C-MA for hallucinations and delusions in Alzheimer's disease
This will test whether ML-007C-MA reduces hallucinations and delusions in people aged 55–90 with Alzheimer's-related psychosis.
-
KarXT for psychosis in people with Alzheimer's disease
This Phase 3 test will see if KarXT reduces hallucinations and delusions in people aged 55–90 who have Alzheimer's-related psychosis.
-
Long-term safety assessment of KarXT for Alzheimer's-related psychosis
This study is testing the long-term safety of a treatment called KarXT for people with Alzheimer's-related psychosis who have already participated in earlier trials.
-
Evaluating KarXT for treating psychosis in Alzheimer's patients
This study is testing a new treatment called KarXT to see if it can help people with Alzheimer's who are experiencing psychosis and prevent them from getting worse.
Quick answers
How many Psychosis Associated With Alzheimer's Disease clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 32 countries. The most sites are in South Korea (4 trials), United States (4 trials), Bulgaria (3 trials), Canada (3 trials), Chile (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.